SCHEMBL6427686

SCHEMBL6427686

C=Cc1nn(C(c2ccccc2)(c2ccccc2)c2ccccc2)c2ccc(C(=O)N[C@H](CO)c3ccccc3)c(OC)c12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 7/20 0.37
IL1B P01584 1/20 0.36
P2RX7 Q99572 1/20 0.36
PHGDH O43175 1/20 0.36
ADORA2A P29274 1/20 0.36
GPR88 Q9GZN0 1/20 0.36
TACR3 P29371 1/20 0.36
ROCK2 O75116 3/20 0.35
ROCK1 Q13464 3/20 0.35
IDH1 O75874 2/20 0.35
ACSS2 Q9NR19 1/20 0.35
RIPK1 Q13546 1/20 0.34
MAPK13 O15264 1/20 0.34
RPS6KA5 O75582 1/20 0.34
MAP4K4 O95819 1/20 0.34
PAK4 O96013 1/20 0.34
PRKCG P05129 1/20 0.34
CDK1 P06493 1/20 0.34
PRKACA P17612 1/20 0.34
RPS6KB1 P23443 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13927790 0.87 PHGDH (0.41) MAPK1PHGDHADORA2AGPR88TACR3
SCHEMBL4146423 0.82 MAPK1 (0.34) MAPK1ACSS2
SCHEMBL4148977 0.79 TSHR (0.36) MAPK1ACSS2
SCHEMBL4140200 0.70 IMPDH2 (0.32)
SCHEMBL5034325 0.70 MAPK1 (0.43) MAPK1ADORA2AGPR88TACR3ROCK2
SCHEMBL4155261 0.67 MAPK1 (0.36) MAPK1ACSS2
SCHEMBL6426231 0.67 ROCK2 (0.42) MAPK1ADORA2AROCK2ROCK1
SCHEMBL5030009 0.67 MAPK1 (0.43) MAPK1ADORA2AROCK2ROCK1IDH1
SCHEMBL6428698 0.67 GPR88 (0.44) MAPK1GPR88ROCK2ROCK1PAK4
SCHEMBL6428627 0.67 MAPK1 (0.41) MAPK1ADORA2AGPR88ROCK2ROCK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050261339-A1 Pyrazole compound and medicinal composition containing the same EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050261339-A1 Pyrazole compound and medicinal composition containing the same CNKSR1, NR3C2, CSNK2B MAPK1 6/4885IL1B 686/4885P2RX7 2317/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.